BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 35212852)

  • 1. Left atrial remodeling in heart failure: the role of sphericity index (the SPHERICAT-HF study).
    Sanna GD; Moccia E; Canonico ME; Sanna S; De Toni C; Santoro C; Masia SL; Saderi L; Sotgiu G; Parodi G
    Int J Cardiovasc Imaging; 2022 Aug; 38(8):1723-1732. PubMed ID: 35212852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between electrocardiographic interatrial blocks and echocardiographic indices of left atrial function in acute heart failure.
    Sanna GD; Argiolas D; Franca P; Saderi L; Sotgiu G; Parodi G
    Heart Vessels; 2022 Jan; 37(1):50-60. PubMed ID: 34091737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
    von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD
    J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between plasma N-terminal pro-brain natriuretic peptide levels and changes in New York Heart Association functional class, left atrial size, left ventricular size and function after mitral and/or aortic valve replacement.
    Elasfar A
    Ann Saudi Med; 2012; 32(5):469-72. PubMed ID: 22871614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Association of plasma amino-terminal pro-A-, B- and C-type natriuretic peptide levels with NYHA grade and echocardiographic derived parameters of cardiac function in heart failure patients].
    Zhao XY; Yang YJ; Zhang J; Kang LM; Wei BQ; Gao XJ; Lü R; Zhang CL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Jun; 37(6):486-90. PubMed ID: 19927626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic accuracy of left atrial remodelling and natriuretic peptide levels for preclinical heart failure.
    Tsai JP; Sung KT; Su CH; Lai YH; Kuo JY; Yun CH; Yen CH; Hou CJ; Wu TH; Peng MC; Hung TC; Yeh HI; Hung CL
    ESC Heart Fail; 2019 Aug; 6(4):723-732. PubMed ID: 30993903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-terminal pro-b-type natriuretic peptide and left atrial function in patients with congestive heart failure and severely reduced ejection fraction.
    Prastaro M; Paolillo S; Savarese G; Dellegrottaglie S; Scala O; Ruggiero D; Gargiulo P; Marciano C; Parente A; Cecere M; Musella F; Chianese D; Scopacasa F; Perrone-Filardi P
    Eur J Echocardiogr; 2011 Jul; 12(7):506-13. PubMed ID: 21685193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of NT-proBNP in children with heart failure younger than 3 years old.
    Iacob D; Butnariu A; Leucuţa DC; Samaşca G; Deleanu D; Lupan I
    Rom J Intern Med; 2017 Jun; 55(2):69-74. PubMed ID: 28118147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of BNP and NT-proBNP in Patients With Heart Failure and Reduced Ejection Fraction.
    Rørth R; Jhund PS; Yilmaz MB; Kristensen SL; Welsh P; Desai AS; Køber L; Prescott MF; Rouleau JL; Solomon SD; Swedberg K; Zile MR; Packer M; McMurray JJV
    Circ Heart Fail; 2020 Feb; 13(2):e006541. PubMed ID: 32065760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma natriuretic peptide levels reflect changes in heart failure symptoms, left ventricular size and function after surgical mitral valve repair.
    Feringa HH; Poldermans D; Klein P; Braun J; Klautz RJ; van Domburg RT; van der Laarse A; van der Wall EE; Dion RA; Bax JJ
    Int J Cardiovasc Imaging; 2007 Apr; 23(2):159-65. PubMed ID: 16941223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The intracardiac concentrations of the N-terminal-pro B-type natriuretic peptide (NT-proBNP) and the determinants of its secretion in patients with atrial fibrillation.
    Streb W; Mitręga K; Szymała M; Woźniak A; Podolecki T; Kalarus Z
    Kardiol Pol; 2018; 76(2):433-439. PubMed ID: 29131295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Baseline plasma NT-proBNP and clinical characteristics: results from the irbesartan in heart failure with preserved ejection fraction trial.
    McKelvie RS; Komajda M; McMurray J; Zile M; Ptaszynska A; Donovan M; Carson P; Massie BM;
    J Card Fail; 2010 Feb; 16(2):128-34. PubMed ID: 20142024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-terminal pro-B-type natriuretic peptide and its relationship with cardiac function in adults with congenital heart disease.
    Eindhoven JA; van den Bosch AE; Ruys TP; Opić P; Cuypers JA; McGhie JS; Witsenburg M; Boersma E; Roos-Hesselink JW
    J Am Coll Cardiol; 2013 Sep; 62(13):1203-12. PubMed ID: 23916937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Left Atrial Structure and Function With Heart Failure in Older Adults.
    Inciardi RM; Claggett B; Minamisawa M; Shin SH; Selvaraj S; Gonçalves A; Wang W; Kitzman D; Matsushita K; Prasad NG; Su J; Skali H; Shah AM; Chen LY; Solomon SD
    J Am Coll Cardiol; 2022 Apr; 79(16):1549-1561. PubMed ID: 35450571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Left atrial enlargement and NT-proBNP as predictors of sudden cardiac death in patients with heart failure.
    Bayes-Genis A; Vazquez R; Puig T; Fernandez-Palomeque C; Fabregat J; Bardají A; Pascual-Figal D; Ordoñez-Llanos J; Valdes M; Gabarrús A; Pavon R; Pastor L; Gonzalez Juanatey JR; Almendral J; Fiol M; Nieto V; Macaya C; Cinca J; Bayes de Luna A;
    Eur J Heart Fail; 2007 Aug; 9(8):802-7. PubMed ID: 17569580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide Levels in Heart Failure Patients With and Without Atrial Fibrillation.
    Kristensen SL; Jhund PS; Mogensen UM; Rørth R; Abraham WT; Desai A; Dickstein K; Rouleau JL; Zile MR; Swedberg K; Packer M; Solomon SD; Køber L; McMurray JJV;
    Circ Heart Fail; 2017 Oct; 10(10):. PubMed ID: 29018174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of the plasma brain natriuretic peptide in differentiating patients with congestive heart failure from other diseases.
    Sirithunyanont C; Leowattana W; Sukumalchantra Y; Chaisupamonkollarp S; Watanawaroon S; Chivatanaporn B; Bhuripanyo K; Mahanonda N
    J Med Assoc Thai; 2003 May; 86 Suppl 1():S87-95. PubMed ID: 12866774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma amino-terminal pro-B-type natriuretic peptide quantification in hypertrophic cardiomyopathy.
    Arteaga E; Araujo AQ; Buck P; Ianni BM; Rabello R; Mady C
    Am Heart J; 2005 Dec; 150(6):1228-32. PubMed ID: 16338263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of perindopril on echocardiographic parameters, NYHA functional class and serum NT-proBNP values in patients with diastolic heart failure.
    Yuksek U; Cerit L; Eren NK; Ergene O
    Cardiovasc J Afr; 2019 Jul/Aug 23; 30(4):222-227. PubMed ID: 31140540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serial measurements of serum NT-proBNP as markers of left ventricular systolic function and remodeling in children with heart failure.
    Rusconi PG; Ludwig DA; Ratnasamy C; Mas R; Harmon WG; Colan SD; Lipshultz SE
    Am Heart J; 2010 Oct; 160(4):776-83. PubMed ID: 20934575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.